BioCardia’s novel CardiAMP stem cell therapy closer to approval in heart failure

CardiAMP treatment entails the patient undergoing a hip bone marrow biopsy to render the cells viable or nonviable. Credit: Shutterstock + Giovanni Cancemi.



  • BioCardia